1-7 of 7
Myeloma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma

Rudra P. Dutta, Santiago Thibaud, Violetta Leshchenko, Meghana Ram, David T. Melnekoff, Sherry Bhalla, Paula Restrepo, Vikas A. Gupta, Benjamin G. Barwick, Scott Newman, Jonathan McCafferty, Feras Hantash, Ajay K. Nooka, Hearn J. Cho, Shambavi Richard, Cesar Rodriguez, Adriana Rossi, Larysa Sanchez, Ajai Chari, Lawrence H. Boise, Sundar Jagannath, Joshua Richter, Samir Parekh, Alessandro Laganà
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (4): 100049.
https://doi.org/10.1016/j.bneo.2024.100049
Published: 2024
Includes: Supplemental data
Journal Articles

Deciphering MARCH5’s impact on multiple myeloma: insights into autophagy regulation and AKT-FOXO3 signaling

Hamed Bashiri, Ahad Khalilnezhad, Haruhito Totani, Joe Yeong, Tae-Hoon Chung, Felicia Wee, Yuezhen Xue, Zhen Wei Neo, Li Yen Chong, Wee Joo Chng, Atsushi Watanabe, Siok-Bian Ng, The Phyu, Toshio Suda
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (4): 100046.
https://doi.org/10.1016/j.bneo.2024.100046
Published: 2024
Includes: Supplemental data
Journal Articles

Lenalidomide, ixazomib, or daratumumab maintenance therapy in multiple myeloma

Eunice Lai, Yu Yang Soon, Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Cinnie Yentia Soekojo, Melissa Ooi, Wee Joo Chng, Sanjay de Mel
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (4): 100042.
https://doi.org/10.1016/j.bneo.2024.100042
Published: 2024
Includes: Supplemental data
Journal Articles

CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies

Ella Troy, Joseph Caporale, Yasemin Sezgin, Marcelo S. F. Pereira, Gregory Behbehani, Justin Lyberger, Dean A. Lee, Meisam Naeimi Kararoudi
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (4): 100032.
https://doi.org/10.1016/j.bneo.2024.100032
Published: 2024
Includes: Supplemental data
Journal Articles

Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma

Priya Choudhry, Corynn Kasap, Bonell Patiño-Escobar, Olivia Gugliemini, Huimin Geng, Vishesh Sarin, Amrik Kang, Audrey Kishishita, Sham Rampersaud, Letitia Sarah, Yu-Hsiu T. Lin, Neha Paranjape, Poornima Ramkumar, Jonathan C. Patton, Makeba Marcoulis, Donghui Wang, Paul Phojanakong, Veronica Steri, Byron Hann, Benjamin G. Barwick, Martin Kampmann, Arun P. Wiita
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (3): 100025.
https://doi.org/10.1016/j.bneo.2024.100025
Published: 2024
Includes: Supplemental data
Journal Articles

Multiple myeloma–associated DIS3 gene is essential for hematopoiesis, but loss of DIS3 is insufficient for myelomagenesis

Hiroto Ohguchi, Yasuyo Ohguchi, Sho Kubota, Kan Etoh, Ai Hamashima, Shingo Usuki, Takako Yokomizo-Nakano, Jie Bai, Takeshi Masuda, Yawara Kawano, Takeshi Harada, Mitsuyoshi Nakao, Takashi Minami, Teru Hideshima, Kimi Araki, Goro Sashida
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (1): 100005.
https://doi.org/10.1016/j.bneo.2024.100005
Published: 2024
Includes: Supplemental data
Journal Articles

Real-world comparison of daratumumab-based regimens in relapsed/refractory multiple myeloma using health record data

Benjamin A. Derman, Jacob Ambrose, Laura L. Fernandes, Christina M. Zettler, Eric Hansen, Andrew J. Belli, Ching-Kun Wang
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (1): 100003.
https://doi.org/10.1016/j.bneo.2024.100003
Published: 2024
Includes: Supplemental data